Search

Isis A. D. Ghali

Examiner (ID: 231)

Most Active Art Unit
1611
Art Unit(s)
1611, 1615
Total Applications
1721
Issued Applications
501
Pending Applications
322
Abandoned Applications
932

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18752450 [patent_doc_number] => 20230355699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => HYPERICUM EXTRACT IN NEEM OIL FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA [patent_app_type] => utility [patent_app_number] => 18/246212 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1790 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246212 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/246212
HYPERICUM EXTRACT IN NEEM OIL FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA Sep 19, 2021 Pending
Array ( [id] => 17334440 [patent_doc_number] => 20220000771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS [patent_app_type] => utility [patent_app_number] => 17/479614 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -96 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479614 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479614
CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS Sep 19, 2021 Pending
Array ( [id] => 17312707 [patent_doc_number] => 20210401755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => SOLID FORMULATION [patent_app_type] => utility [patent_app_number] => 17/471330 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6857 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471330 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/471330
Solid formulation Sep 9, 2021 Issued
Array ( [id] => 17312893 [patent_doc_number] => 20210401941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS [patent_app_type] => utility [patent_app_number] => 17/469032 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/469032
MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS Sep 7, 2021 Pending
Array ( [id] => 18724319 [patent_doc_number] => 20230338455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL COMPRISING ORANGE-DERIVED EXTRACELLULAR VESICLES [patent_app_type] => utility [patent_app_number] => 18/044604 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9236 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044604 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044604
PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL COMPRISING ORANGE-DERIVED EXTRACELLULAR VESICLES Sep 7, 2021 Pending
Array ( [id] => 17312709 [patent_doc_number] => 20210401757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH OLANZAPINE AND METFORMIN [patent_app_type] => utility [patent_app_number] => 17/464587 [patent_app_country] => US [patent_app_date] => 2021-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464587 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/464587
SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH OLANZAPINE AND METFORMIN Aug 31, 2021 Abandoned
Array ( [id] => 17312710 [patent_doc_number] => 20210401758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH TRAZODONE [patent_app_type] => utility [patent_app_number] => 17/464616 [patent_app_country] => US [patent_app_date] => 2021-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7701 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464616 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/464616
SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH TRAZODONE Aug 31, 2021 Abandoned
Array ( [id] => 20401207 [patent_doc_number] => 12491166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Method of delivering an active compound and delivery device for use in the same [patent_app_type] => utility [patent_app_number] => 17/460820 [patent_app_country] => US [patent_app_date] => 2021-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 9860 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460820 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/460820
Method of delivering an active compound and delivery device for use in the same Aug 29, 2021 Issued
Array ( [id] => 20401207 [patent_doc_number] => 12491166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Method of delivering an active compound and delivery device for use in the same [patent_app_type] => utility [patent_app_number] => 17/460820 [patent_app_country] => US [patent_app_date] => 2021-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 9860 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460820 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/460820
Method of delivering an active compound and delivery device for use in the same Aug 29, 2021 Issued
Array ( [id] => 18829639 [patent_doc_number] => 20230398163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => FRUIT EXTRACTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES [patent_app_type] => utility [patent_app_number] => 18/022877 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16463 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -67 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022877 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022877
FRUIT EXTRACTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Aug 23, 2021 Pending
Array ( [id] => 17426993 [patent_doc_number] => 20220054701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => LIQUID MEDICAL MATERIAL [patent_app_type] => utility [patent_app_number] => 17/407982 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4842 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407982 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/407982
Liquid hemostatic medical material Aug 19, 2021 Issued
Array ( [id] => 19096530 [patent_doc_number] => 20240115757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY [patent_app_type] => utility [patent_app_number] => 18/043305 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043305 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043305
METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY Aug 19, 2021 Pending
Array ( [id] => 19096530 [patent_doc_number] => 20240115757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY [patent_app_type] => utility [patent_app_number] => 18/043305 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043305 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043305
METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY Aug 19, 2021 Pending
Array ( [id] => 17412621 [patent_doc_number] => 20220047525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS [patent_app_type] => utility [patent_app_number] => 17/401598 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -68 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401598 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401598
TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS Aug 12, 2021 Pending
Array ( [id] => 17412621 [patent_doc_number] => 20220047525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS [patent_app_type] => utility [patent_app_number] => 17/401598 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -68 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401598 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401598
TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS Aug 12, 2021 Pending
Array ( [id] => 17412621 [patent_doc_number] => 20220047525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS [patent_app_type] => utility [patent_app_number] => 17/401598 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -68 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401598 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401598
TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS Aug 12, 2021 Pending
Array ( [id] => 18565716 [patent_doc_number] => 20230256043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => FORMULATION PRODUCT [patent_app_type] => utility [patent_app_number] => 18/015952 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015952 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015952
FORMULATION PRODUCT Jul 12, 2021 Pending
Array ( [id] => 18565716 [patent_doc_number] => 20230256043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => FORMULATION PRODUCT [patent_app_type] => utility [patent_app_number] => 18/015952 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015952 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015952
FORMULATION PRODUCT Jul 12, 2021 Pending
Array ( [id] => 17334557 [patent_doc_number] => 20220000888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => OPHTHALMIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/359120 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359120 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/359120
OPHTHALMIC COMPOSITIONS Jun 24, 2021 Abandoned
Array ( [id] => 17290842 [patent_doc_number] => 20210386681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => AMMONIA PAD WITH RELEASABLE SEAL [patent_app_type] => utility [patent_app_number] => 17/347256 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347256 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347256
Ammonia pad with releasable seal Jun 13, 2021 Issued
Menu